Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
7.67
+0.07 (0.92%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Exagen Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 71.12 | 66.58 | 55.64 | 52.55 | 45.56 | 48.3 | |
Revenue Growth | 20.83% | 19.65% | 5.89% | 15.33% | -5.67% | 15.07% |
Cost of Revenue | 29.42 | 27.78 | 22.53 | 23.09 | 24.21 | 20.59 |
Gross Profit | 41.7 | 38.8 | 33.11 | 29.46 | 21.35 | 27.71 |
Selling, General & Admin | 48.45 | 46.62 | 41.37 | 47.43 | 52.02 | 44.54 |
Research & Development | 6.47 | 6.25 | 5.38 | 4.87 | 9.48 | 7.24 |
Operating Expenses | 54.91 | 52.87 | 46.75 | 52.29 | 61.5 | 51.78 |
Operating Income | -13.21 | -14.07 | -13.64 | -22.84 | -40.15 | -24.07 |
Interest Expense | -5.12 | -4.32 | -2.23 | -2.34 | -2.45 | -2.63 |
Interest & Investment Income | 0.29 | 0.29 | 0.77 | 1.52 | 0.83 | 0.02 |
Other Non Operating Income (Expenses) | -0.22 | - | - | - | - | - |
EBT Excluding Unusual Items | -18.26 | -18.1 | -15.1 | -23.66 | -41.77 | -26.68 |
Impairment of Goodwill | - | - | - | - | -5.51 | - |
Asset Writedown | - | - | - | - | -0.4 | - |
Other Unusual Items | -0.61 | -1.8 | - | - | - | - |
Pretax Income | -18.87 | -19.9 | -15.1 | -23.66 | -47.67 | -26.68 |
Income Tax Expense | 0.05 | 0.05 | 0.01 | 0.03 | -0.28 | 0.18 |
Net Income | -18.92 | -19.95 | -15.12 | -23.69 | -47.39 | -26.85 |
Net Income to Common | -18.92 | -19.95 | -15.12 | -23.69 | -47.39 | -26.85 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 24 | 22 | 18 | 18 | 17 | 16 |
Shares Outstanding (Diluted) | 24 | 22 | 18 | 18 | 17 | 16 |
Shares Change | 23.90% | 18.43% | 2.96% | 3.50% | 6.95% | 26.43% |
EPS (Basic) | -0.80 | -0.93 | -0.83 | -1.34 | -2.77 | -1.68 |
EPS (Diluted) | -0.80 | -0.93 | -0.83 | -1.34 | -2.77 | -1.68 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.59 | -14.27 | -13.79 | -15.29 | -36.46 | -22.64 |
Free Cash Flow Per Share | -0.32 | -0.66 | -0.76 | -0.86 | -2.13 | -1.42 |
Gross Margin | 58.64% | 58.28% | 59.51% | 56.05% | 46.86% | 57.37% |
Operating Margin | -18.57% | -21.13% | -24.51% | -43.46% | -88.11% | -49.83% |
Profit Margin | -26.61% | -29.97% | -27.16% | -45.08% | -104.00% | -55.59% |
Free Cash Flow Margin | -10.67% | -21.43% | -24.79% | -29.10% | -80.03% | -46.87% |
EBITDA | -10.77 | -11.95 | -11.91 | -20.67 | -38.59 | -23.12 |
EBITDA Margin | -15.15% | -17.95% | -21.41% | -39.33% | -84.70% | -47.87% |
D&A For EBITDA | 2.44 | 2.12 | 1.72 | 2.17 | 1.56 | 0.95 |
EBIT | -13.21 | -14.07 | -13.64 | -22.84 | -40.15 | -24.07 |
EBIT Margin | -18.57% | -21.13% | -24.51% | -43.46% | -88.11% | -49.83% |